Skip to main content

Key Customer Information

Seqirus Canada is pleased to have the opportunity to work with you for the up-coming 2021-2022 influenza season.


2021-2022 WHO Strain Recommendation

Seqirus is a central partner to clinicians and pharmacists, providing a range of vaccines to offer their patients and consumers innovative options.

Underscoring our customer relationships is Seqirus’ work with leading Canadian researchers, healthcare professionals and public health leaders to advance scientific knowledge and global influenza research.

National & Provincial Recommendations

NACI Seasonal Influenza Vaccine Statement

Please click on the links below to access additional customer information.

Seqirus letter to customers March 23, 2020

Account Opening Forms

Terms and conditions 

 

List of references used on our promotional material

Reference List